BT Wealth Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-60,000
Closed -$118K 59
2020
Q1
$118K Buy
60,000
+2,991
+5% +$5.88K 0.07% 52
2019
Q4
$163K Hold
57,009
0.08% 63
2019
Q3
$209K Hold
57,009
0.12% 51
2019
Q2
$189K Buy
57,009
+7,009
+14% +$23.2K 0.11% 52
2019
Q1
$256K Hold
50,000
0.15% 46
2018
Q4
$249K Buy
+50,000
New +$249K 0.11% 85